Northwest Biotherapeutics Inc
NWBO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001072379
No open-market purchases or sales by Northwest Biotherapeutics Inc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $413.6K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Northwest Biotherapeutics Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 316.5K | 393.7K | +77.2K (+24.4%) |
| Value | $472.0K | $577.0K | +$105.0K (+22.2%) |
New holders (4)
Institutions that held Northwest Biotherapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kovack Advisors, Inc. | 25,000 | $37.0K | 0.00% |
| Fisher Asset Management, LLC | 14,500 | $21.0K | 0.00% |
| AlphaMark Advisors, LLC | 14,007 | $21.0K | 0.01% |
| Steward Partners Investment Advisory, LLC | 7,000 | $10.0K | 0.00% |
Sold out (1)
Institutions that held Northwest Biotherapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Eudaimonia Partners, LLC | 4,700 | $7.00K |